Tian T, Jing J, Li Y, Wang Y, Deng X, Shan Y
Long term safety Clinical trials have shown Invokana to be associated with a fall in aGFR (estimated glomerular filtration rate), a marker which indicates how well the kidneys are working
Someone who races to 15 mg in the first six months has nowhere left to go when they hit a plateau at month ten, while someone who stayed at 5 mg or 7.5 mg as long as it kept working still has multiple increases in reserve
GLP-1 medications (like semaglutide) can generally be used safely in people with hypothyroidism if thyroid levels are well controlled
Destaca sus buenas propiedades cognitivas y su capacidad para mejorar las funciones cerebrales, ayudando a prevenir problemas neurolgicos y mejorando la memoria
Learn more about my approach as a board-certified family physician and aesthetic expert